(Q52886014)

9 May 2018

title

DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy. (English)

1 reference

9 May 2018

Berthold Hocher

10

0 references

author name string

Markus L Alter

1

1 reference

9 May 2018

Ina M Ott

2

1 reference

9 May 2018

Karoline von Websky

3

1 reference

9 May 2018

Oleg Tsuprykov

4

1 reference

9 May 2018

Yuliya Sharkovska

5

1 reference

9 May 2018

Katharina Krause-Relle

6

1 reference

9 May 2018

Jens Raila

7

1 reference

9 May 2018

Andrea Henze

8

1 reference

9 May 2018

Thomas Klein

9

1 reference

9 May 2018

publication date

15 October 2012

1 reference

9 May 2018

Kidney and Blood Pressure Research

published in

1 reference

9 May 2018

volume

36

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

119-130

1 reference

9 May 2018

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

cites work

1 reference

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

21 January 2018

1 reference

Angiotensin II type 1 receptor blockers

21 January 2018

1 reference

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists

21 January 2018

1 reference

Renal and cardiac effects of DPP4 inhibitors--from preclinical development to clinical research

21 January 2018

1 reference

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers

21 January 2018

1 reference

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

21 January 2018

1 reference

Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects.

21 January 2018

1 reference

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers

21 January 2018

1 reference

Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.

21 January 2018

1 reference

Mouse models of diabetic nephropathy

21 January 2018

1 reference

Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice

21 January 2018

1 reference

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

21 January 2018

1 reference

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

21 January 2018

1 reference

T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm

21 January 2018

1 reference

The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide

21 January 2018

1 reference

Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy

21 January 2018

1 reference

New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy

21 January 2018

1 reference

Renal protection in diabetes: lessons from ONTARGET.

21 January 2018

1 reference

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

Proteinuria and the risk of developing end-stage renal disease

21 January 2018

1 reference

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

21 January 2018

1 reference

Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition

21 January 2018

1 reference

Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line

21 January 2018

1 reference

Vascular calcification: the killer of patients with chronic kidney disease

21 January 2018

1 reference

Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?

21 January 2018

1 reference

A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress

21 January 2018

1 reference

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

21 January 2018

1 reference

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.

21 January 2018

1 reference

Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis

21 January 2018

1 reference

Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure

21 January 2018

1 reference

Adenosine A1 receptor antagonists in clinical research and development

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000341487

1 reference

9 May 2018

1 reference

9 May 2018